Newsroom
The latest from Amide
Amide Technologies Appoints Co-Founder and MIT Chemistry Professor as CEO
Dr. Brad Pentelute to Lead Amide’s Revolutionary Peptide Manufacturing Platform Cambridge, MA –...
Amide Technologies Announces Complex Peptide Manufacturing Platform, Raises $16.5M to Expedite Frontier Drug Discovery
Spun out of MIT, Amide partners with biopharmas to accelerate peptide drug...
Parallel Automated Flow Synthesis of Covalent Protein Complexes That Can Inhibit MYC-Driven Transcription
INTERESTED IN
LEARNING MORE?
Amide is accepting customers looking for a reliable source for hard-to-obtain peptides.